Dr Jeffrey Carson, currently serving as the Provost, New Brunswick at Rutgers Biomedical and Health Sciences, brings a wealth of experience and leadership to the field of medicine. Formerly the Chief of the Division of General Internal Medicine until 2015, he holds the esteemed position of Distinguished Professor of Medicine and occupies the Richard C. Reynolds, M.D. Chair in General Internal Medicine.
Dr Carson earned his MD degree from Hahnemann Medical College, where he also undertook residency and served as Chief Resident in Internal Medicine. His commitment to advancing medical knowledge is evident in his research training in clinical epidemiology during a prestigious two-year Henry J. Kaiser Fellowship at the University of Pennsylvania. Further enhancing his expertise, Dr. Carson became a Fogarty Senior International Fellow at the University of Oxford, England, from 1995–1996, receiving extensive training in clinical trials.
As a board-certified internist practising both office and hospital-based Internal Medicine, Dr Carson has been honoured with five teaching awards and has consistently featured on the annual "best" doctor list since 1998. Internal Medicine residents have recognized his dedication with two research mentor awards.
Dr. Carson's prowess in clinical trials is underscored by his appointment to the Clinical Trials Review Committee at the National Heart, Lung, and Blood Institutes, where he served as Chair during his fifth year. Additionally, he has contributed as a member and chair of multiple clinical trial Data Safety Monitoring Boards.
The crux of Dr Carson's research lies in assessing the risk of anaemia and determining indications for blood transfusion. His groundbreaking work has graced prestigious journals such as the New England Journal of Medicine, Lancet, JAMA, and Annals of Internal Medicine. Notably, his trial published in the New England Journal of Medicine and the Lancet was recognized as one of the 34 key research findings published in 2012, funded by the NIH. His ongoing work includes National Heart, Lung, and Blood Institutes-supported trials in transfusion in patients with myocardial infarction, plasma use, and blood utilization in China.
Dr Carson's leadership extends to Clinical Guidelines on Red Blood Cell Transfusion, systematic review and meta-analysis evaluating red blood cell transfusions, and his role as the author of the chapter on red blood cell transfusion in the online textbook UpToDate. His expertise has been acknowledged with accolades such as the Edward J. Ill Excellence in Medicine Award: Outstanding Medical Research Scientist Award for Clinical Research and the Excellence in Research Award from the Foundation of UMDNJ. He was honoured with the Margot S. Kruskall Lectureship at Harvard Medical School and served as the Keynote speaker at the State of Science on Transfusion Medicine at NHLBI. Recently, he was inducted into the National Blood Foundation Hall of Fame and elected as a member of the American Association of Physicians. Dr Carson's contributions to medicine continue to shape the landscape of clinical research and patient care.
